Date: 2025-06-13 12:26:56 Source: Author: Research Views: 311
Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, today announced that it has secured £3.5m in new equity financing, including £2.5m from lead investor